Collagen is the most abundant structural protein in the body — forming the scaffold of skin, joints, tendons, bone, and vascular tissue. Collagen synthesis declines ~1% per year after age 25, driving visible aging, joint degradation, and impaired wound healing. Peptide research directly stimulates fibroblast collagen output, providing the most targeted intervention available for restoring collagen infrastructure.
1. GHK-Cu — Direct Fibroblast Activation
GHK-Cu (copper peptide) is the most studied and validated peptide for collagen synthesis. It directly activates fibroblasts to produce collagen type I, III, and V, stimulates elastin and glycosaminoglycan synthesis, and upregulates the TGF-β pathways governing extracellular matrix remodeling. Decades of research confirm its role as the benchmark collagen-stimulating peptide.
Dosing Protocol: Topical: 0.5–2% GHK-Cu serum/cream applied daily to target areas. Systemic: 1–2 mg SubQ daily. Combine for maximal effect. Continuous use 8–12 weeks minimum for structural collagen remodeling.
2. BPC-157 — Fibroblast Proliferation / Angiogenesis
BPC-157 upregulates growth hormone receptors on fibroblasts, dramatically increasing their sensitivity to GH-driven collagen synthesis signals. It also promotes angiogenesis — the formation of new blood vessels needed to deliver oxygen and nutrients to fibroblasts in collagen-intensive repair zones.
Dosing Protocol: 250–500 mcg SubQ daily. Can be injected near target areas (skin, joint, tendon). Cycle: 6–8 weeks.
3. TB-500 — Actin/Collagen Matrix Integration
TB-500 (Thymosin Beta-4) promotes the migration and differentiation of fibroblasts into collagen-producing cells and supports the actin cytoskeletal reorganization required for efficient collagen secretion. It improves the quality of newly formed collagen matrix and reduces fibrotic scar formation in healing tissue.
Dosing Protocol: 2 mg SubQ twice weekly for 4–6 weeks (loading), then 2 mg weekly maintenance. Best stacked with GHK-Cu and BPC-157.
4. IGF-1 LR3 — Growth Factor Amplification
IGF-1 is a potent activator of fibroblast proliferation and collagen gene transcription. IGF-1 LR3 provides sustained IGF-1 signaling that amplifies the collagen-stimulating effects of GHK-Cu and GH secretagogues, particularly in skin and joint tissue where collagen turnover is highest.
Dosing Protocol: 20–40 mcg SubQ daily. Cycle: 4 weeks on, 4–6 weeks off.
GHK-Cu is the direct collagen synthesis driver while BPC-157 ensures fibroblasts have the vascular supply and receptor sensitivity needed to respond. TB-500 orchestrates the cytoskeletal mechanics of collagen production and IGF-1 LR3 amplifies the entire process via growth factor signaling — creating a multi-level collagen synthesis cascade.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).